Celebrating 20 Years of IP Excellence

Weekly Patent News

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

In this week’s patent news: After Natco, Bajaj Healthcare files compulsory license application against Eli Lilly for Baricitinib; EPO Enlarged Board of Appeal issues Decision G4/19 – Applications can be refused for ‘double patenting'; IP5 meet virtually to improve application and examination procedures for AI patents; EPO launches ‘EPO Data Hub’ mobile app and Joint Release by WHO, WTO and WIPO Indian Patent News After Natco, Bajaj Healthcare files compulsory license application against Eli Lilly for Baricitinib Drug manufacturer, Bajaj Healthcare…

Read more

Latest Patent Cases in 2021 - Part 1

Latest Patent Cases in 2021 – Part 1

H. Lundbeck A/S & Anr. vs Symed Labs Limited In this case, the patent holder (plaintiff) and the defendant settled a patent suit even before notice was served, and filed an application asking the Court to decree the suit as per the terms of the settlement agreement, which the Court did. The Court also refunded the Court fee payed by the plaintiff in the case. This settlement agreement between the parties is interesting because it dealt with use of the…

Read more

Free Session on Patent Licensing and Commercialization

Free Session on Patent Licensing and Commercialization by BananaIP and K-Tech CoE Data Science & AI – NASSCOM

The Certificate MasterClass on Intellectual Property has now reached the last phase. The final session scheduled on 17th June, 2021 (Thursday) will focus on making money, and gaining value out of patents. It will cover patent valuation, licensing and commercialization. You may register for the upcoming session for free here Patent Valuation, Licensing and Commercialization It is important for businesses, especially startups and SMEs, to understand how commercializing patents works, and what options are available. The legal framework, albeit minimal, is…

Read more

Weekly Patent News

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

In this week’s patent news - Want to know how to file a patent? or expedite the patent process? Join us this week; Nokia and Daimer settle SEP patent dispute, sign patent licensing agreement; EU submits alternative proposal to WTO against IP waiver; and USPTO announces change to its implementation of structured text filing. Want to know how to file a patent? or expedite the patent process? Join us this week BananaIP in association with Nasscom will be…

Read more

Register for Session 3 of the Free Masterclass on Intellectual Property by BananaIP and NASSCOM

Upcoming: Free Webinar on Patent Process and Strategy – Session 3 of the Master Class on IP by BananaIP and NASSCOM’s KTech CoE on Data Science

The Certificate Master Class  on IP by BananaIP Counsels and NASSCOM's KTech CoE on Data Science  has completed two weeks, and the third session is coming up this week on 10th June, 2021 (Thursday). During this session, reputed patent attorneys from BananaIP will cover the patent process and related strategic options for businesses. You may register for the session for free at this link: here What will this session cover? With primary focus on patent procedure and…

Read more

Assessing Patentability of Technologies and Performing Patent Searches

Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IP

The second session of BananaIP and NASSCOM K-Tech CoE Data Science & AI's first of its kind 'Masterclass on Intellectual Property’ for Start Ups hosted on 3rd June, 2021 witnessed over 200 participants which included Start Ups, Entrepreneurs, Prospective Entrepreneurs, Independent Inventors/Creators, Artists, SMEs, and MNCs coming together to garner knowledge on the Business of Intellectual Property, via an online meeting platform. Proceedings of the Session The second session was hosted by Mr. Sudeep Kumar Das, from K-Tech CoE Data Science…

Read more

UPDATED PATENT, TRADE MARK, COPYRIGHT AND OTHER ACTS

Updated Patent, Trade Mark, Copyright and other Acts

Following the ordinance abolishing the IPAB, we updated all relevant intellectual property statutes to reflect the amended provisions. We are hereby sharing  the links to the amended statutes along with word and pdf versions of the Acts in accessible formats. You may read about the changes in different statutes in  the series of posts we had carried earlier at the following links: Patents Act, Trade Marks Act, Copyrights Act, Plant Varieties Act, and Geographical Indications Act. The list below provides links…

Read more

The featured image is a quote by John F. Kennedy which reads "There are risks and costs to action. But they are far less than the risks of comfortable inaction"

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

During the last two days, two interesting articles addressing accessibility of medical products and methods were published. While one article in 'The Hindu' spoke about capitalism and its inherent hurdles to access, another article written by Professor Arul Scaria in 'The Wire' argued against Niti Aayog's approach towards access to COVID vaccines and medicines. In his article, Professor Scaria specifically pointed out that Government's reluctance to use the compulsory licensing mechanism as a part of the COVID vaccine/medicine access scheme…

Read more

Weekly Patent News

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

In this week’s patent news: Patent Office notifies Supreme Court’s order on Extensions of Timelines; Patent office announces JPO/IPR Training Course FY 2021; BananaIP and NASSCOM to organize a Master Class on IP; Panacea Biotec accuses Sanofi of patent infringement, files suit; Natco and Eli Lilly sign patent license agreement for production of Barcitinib; NATCO and Eli Lilly sign patent license agreement for production of Barcitinib; India and South Africa propose three-year patent waiver. Patent Office notifies Supreme Court’s…

Read more

Connect with Us

BananaIP Counsels

No.40, 3rd Main Road, JC Industrial Estate, Kanakapura Road, Bangalore – 560 062.

Telephone: +91-76250 93758+91-80-49536207 | +91-80-26860414/24/34
Email: contact@bananaip.com

Please enable JavaScript in your browser to complete this form.
Checkboxes

© 2004-2024 BananaIP Counsels. All Rights Reserved.